Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma

CAR T-cell therapy has revolutionized the treatment of hematologic malignancies, although its use may be complicated by toxicities, including cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and infections. Invasive fungal disease (IFD) has been report...

Descripción completa

Detalles Bibliográficos
Autores principales: Little, Jessica S., Aleissa, Muneerah M., Beluch, Katherine, Gonzalez-Bocco, Isabel H., Marty, Francisco M., Manne-Goehler, Jennifer, Koo, Sophia, Hammond, Sarah P., Jacobson, Caron A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631654/
https://www.ncbi.nlm.nih.gov/pubmed/35802461
http://dx.doi.org/10.1182/bloodadvances.2022007474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631654/
https://www.ncbi.nlm.nih.gov/pubmed/35802461
http://dx.doi.org/10.1182/bloodadvances.2022007474

Ejemplares similares